Forging a position as an innovative player in
infectious disease vaccines and therapies

Home
About
Our Technology
Business Development
- Partner Network
- Licensing Strategy and Available Licenses
Investor Relations
Contact Us
- Corporate directory

BioDiem » Newsletters

Newsletters

Opal Biosciences Investor Briefing, Sydney 13 July 2015

Opal Biosciences Investor Briefing, Melbourne 14 July 2015

Latest News

Notice of Meeting

November 8, 2021

Notice of Meeting

Read More
2021 BioDiem Annual Report

November 4, 2021

2021 Annual report

Read More

Join our email list!

Join our email distribution list to be updated with announcements.

© Copyright 2014 BioDiem

Privacy Policy
Terms and conditions